Table 1_Clinical course, treatment and outcome of severe pneumocystis pneumonia in patient

A 5-year prospective single-center ICU study of 107 patients with autoimmune or inflammatory diseases and severe Pneumocystis pneumonia. The dataset includes clinical, laboratory, radiological, therapeutic, and outcome data, with analysis of risk factors for treatment failure and 28-day ICU mortality. It was authored by Yan Shi and last updated on 2026-05-27.

Use Cases

• Predicting 28-day ICU mortality based on variables like PaO2/FiO2 ratio and initial treatment failure mentioned in the description.
• Identifying risk factors for initial treatment failure based on features such as coinfection and underlying connective tissue disease.
• Analyzing the association between persistent low CD4+ T-cell counts and patient outcomes in severe PCP.
• Studying the progression of pulmonary fibrosis in patients with severe PCP using follow-up imaging data.

Strengths

• Prospective study design over a 5-year period.
• Includes data from 107 enrolled patients with detailed clinical and outcome variables.
• Multivariable regression analysis identifies specific risk factors with odds ratios and confidence intervals (e.g., OR 10.591 for initial treatment failure).

Limitations

• Row count and column-level documentation are absent; field semantics must be inferred after download.
• Data is from a single-center study, which may limit generalizability.
• The dataset is small, at 31.0 KB, indicating limited scope.

Provenance

Source

figshare, author Yan Shi.

Collection Method

Prospective data collection from a single ICU.

Time Range

Study conducted over a 5-year period (specific years not provided).

Freshness

Last updated 2026-05-27 11:51:46; freshness should be verified.